Development of a Polygenic Risk Score for BMI to Assess the Genetic Susceptibility to Obesity and Related Diseases in the Korean Population

被引:3
|
作者
Yoon, Nara [1 ]
Cho, Yoon Shin [1 ]
机构
[1] Hallym Univ, Dept Biomed Sci, Chunchon 24252, South Korea
关键词
obesity; body mass index; polygenic risk score; single-nucleotide polymorphism; genome-wide association study; disease risk assessment; BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; LOCI; METAANALYSIS;
D O I
10.3390/ijms241411560
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hundreds of genetic variants for body mass index (BMI) have been identified from numerous genome-wide association studies (GWAS) in different ethnicities. In this study, we aimed to develop a polygenic risk score (PRS) for BMI for predicting susceptibility to obesity and related traits in the Korean population. For this purpose, we obtained base data resulting from a GWAS on BMI using 57,110 HEXA study subjects from the Korean Genome and Epidemiology Study (KoGES). Subsequently, we calculated PRSs in 13,504 target subjects from the KARE and CAVAS studies of KoGES using the PRSice-2 software. The best-fit PRS for BMI (PRSBMI) comprising 53,341 SNPs was selected at a p-value threshold of 0.064, at which the model fit had the greatest R-2 score. The PRSBMI was tested for its association with obesity-related quantitative traits and diseases in the target dataset. Linear regression analyses demonstrated significant associations of PRSBMI with BMI, blood pressure, and lipid traits. Logistic regression analyses revealed significant associations of PRSBMI with obesity, hypertension, and hypo-HDL cholesterolemia. We observed about 2-fold, 1.1-fold, and 1.2-fold risk for obesity, hypertension, and hypo-HDL cholesterolemia, respectively, in the highest-risk group in comparison to the lowest-risk group of PRSBMI in the test population. We further detected approximately 26.0%, 2.8%, and 3.9% differences in prevalence between the highest and lowest risk groups for obesity, hypertension, and hypo-HDL cholesterolemia, respectively. To predict the incidence of obesity and related diseases, we applied PRSBMI to the 16-year follow-up data of the KARE study. Kaplan-Meier survival analysis showed that the higher the PRSBMI, the higher the incidence of dyslipidemia and hypo-HDL cholesterolemia. Taken together, this study demonstrated that a PRS developed for BMI may be a valuable indicator to assess the risk of obesity and related diseases in the Korean population.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Polygenic risk score model for renal cell carcinoma in the Korean population and relationship with lifestyle-associated factors
    Hong, Joo Young
    Han, Jang Hee
    Jeong, Seung Hwan
    Kwak, Cheol
    Kim, Hyeon Hoe
    Jeong, Chang Wook
    BMC GENOMICS, 2024, 25 (01)
  • [22] Development of a genetic risk score for obesity predisposition evaluation
    Narges Damavandi
    Armin Soleymaniniya
    Sobhan Bahrami Zadegan
    Mohammad Hasan Samiee Aref
    Sirous Zeinali
    Molecular Genetics and Genomics, 2022, 297 : 1495 - 1503
  • [23] Development of a genetic risk score for obesity predisposition evaluation
    Damavandi, Narges
    Soleymaniniya, Armin
    Zadegan, Sobhan Bahrami
    Aref, Mohammad Hasan Samiee
    Zeinali, Sirous
    MOLECULAR GENETICS AND GENOMICS, 2022, 297 (06) : 1495 - 1503
  • [24] Development and validation of a lung cancer polygenic risk score incorporating susceptibility variants for risk factors
    Ma, Zhimin
    Zhu, Zhaopeng
    Pang, Guanlian
    Gong, Feilong
    Gao, Jiaxin
    Ge, Wenjing
    Wang, Guoqing
    Zhu, Mingxuan
    Gong, Linnan
    Li, Qiao
    Ji, Chen
    Fu, Yating
    Jin, Chen
    Ma, Hongxia
    Ji, Yong
    Zhu, Meng
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (05) : 953 - 963
  • [25] Modeling BMI z score lability during childhood as a function of child temperament and genetic risk for obesity
    Liu, Chang
    Neiderhiser, Jenae M.
    Ram, Nilam
    Leve, Leslie D.
    Shaw, Daniel S.
    Natsuaki, Misaki N.
    Reiss, David
    Ganiban, Jody M.
    OBESITY, 2023, 31 (10) : 2593 - 2602
  • [26] Associations of air pollution with obesity and body fat percentage, and modification by polygenic risk score for BMI in the UK Biobank
    Furlong, Melissa A.
    Klimentidis, Yann C.
    ENVIRONMENTAL RESEARCH, 2020, 185
  • [27] A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
    Whitfield, John B.
    Schwantes-An, Tae-Hwi
    Darlay, Rebecca
    Aithal, Guruprasad P.
    Atkinson, Stephen R.
    Bataller, Ramon
    Botwin, Greg
    Chalasani, Naga P.
    Cordell, Heather J.
    Daly, Ann K.
    Day, Christopher P.
    Eyer, Florian
    Foroud, Tatiana
    Gleeson, Dermot
    Goldman, David
    Haber, Paul S.
    Jacquet, Jean-Marc
    Liang, Tiebing
    Liangpunsakul, Suthat
    Masson, Steven
    Mathurin, Philippe
    Moirand, Romain
    McQuillin, Andrew
    Moreno, Christophe
    Morgan, Marsha Y.
    Mueller, Sebastian
    Muellhaupt, Beat
    Nagy, Laura E.
    Nahon, Pierre
    Nalpas, Bertrand
    Naveau, Sylvie
    Perney, Pascal
    Pirmohamed, Munir
    Seitz, Helmut K.
    Soyka, Michael
    Stickel, Felix
    Thompson, Andrew
    Thursz, Mark R.
    Trepo, Eric
    Morgan, Timothy R.
    Seth, Devanshi
    JOURNAL OF HEPATOLOGY, 2022, 76 (02) : 275 - 282
  • [28] Cardiometabolic diseases, polygenic risk score, APOE genotype, and risk of incident dementia: A population-based prospective cohort study
    Chen, Yanchun
    Zhang, Yuan
    Li, Shu
    Zhou, Lihui
    Li, Huiping
    Li, Dun
    Wang, Yaogang
    Yang, Hongxi
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2023, 105
  • [29] Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes
    Xiaohao Ruan
    Da Huang
    Jingyi Huang
    James Hok-Leung Tsu
    Rong Na
    Journal of Translational Medicine, 21
  • [30] Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes
    Ruan, Xiaohao
    Huang, Da
    Huang, Jingyi
    Tsu, James Hok-Leung
    Na, Rong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)